GSK 366
GSK 366 is a potent kynurenine-3-monooxygenase (KMO) inhibitor with IC50s of 2.3 nM and 0.7 nM for human KMO and P. fluorescens-KMO (Pf-KMO), respectively[1].
Product Specifications
CAS Number
1953157-39-5
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/gsk-366.html
Purity
99.80
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(O)CCC1=NOC2=C1C=C(Cl)C(O[C@@H](C3=NN=C(C)C=C3)C)=C2
Molecular Formula
C17H16ClN3O4
Molecular Weight
361.78
References & Citations
[1]Hutchinson JP, et al. Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase. Nat Commun. 2017 Jun 12;8:15827.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GAP-01-20 1 mL
Colloidal Gold Conjugated Rabbit Affinity Purified Antibody to Protein A, 20nm
Sign In for Pricing
View Details 
P038-594-1ML 1x 1 mL
DNP Recombinant Monoclonal Rat Antibody (rLO-DNP-2), CF®594 Conjugate - Biotium Choice
Sign In for Pricing
View Details 
BNUM2488-50 1x 50 µL
TIMP2 (Tissue Inhibitor of Metalloproteinase 2) (TIMP2/2488R), 1mg/mL
Sign In for Pricing
View Details 